Disease Progression
Showing 51 - 75 of >10,000
COPD Trial in Canada, United Kingdom, United States (Azithromycin, HP xenon (¹²?XE))
Recruiting
- Chronic Obstructive Pulmonary Disease
- Azithromycin
- HP xenon (¹²⁹XE)
-
Kansas City, Kansas
- +5 more
Feb 2, 2023
Macular Damage in Early Glaucoma and Progression
Recruiting
- Glaucoma
-
New York, New YorkCUIMC Harkness Eye Institute
Nov 4, 2022
Advanced or Metastatic Cancer, Fear of Cancer Progression, Metacognition-based Intervention Trial (ConquerFear intervention,
Not yet recruiting
- Advanced or Metastatic Cancer
- +4 more
- ConquerFear intervention
- +2 more
- (no location specified)
Jan 12, 2023
COPD Exacerbation, Pneumonia, Respiratory Tract Infections Trial (Rapid diagnostics)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease Exacerbation
- +2 more
- Rapid diagnostics
- (no location specified)
Oct 23, 2023
Chronic Hepatitis B Trial in Shatin (Tenofovir alafenamide, Entecavir)
Not yet recruiting
- Chronic Hepatitis B
- Tenofovir alafenamide
- Entecavir
-
Shatin, Hong KongPrince of Wales Hospital
Jun 15, 2022
Renal Insufficiency, Chronic Trial in Mansoura, Tanta (Metformin, Empagliflozin, Standard therapy)
Recruiting
- Renal Insufficiency, Chronic
- Metformin
- +2 more
-
Mansoura, Dakahlia Governorate, Egypt
- +1 more
May 12, 2022
Tracking of Knee Osteoarthritis
Not yet recruiting
- Knee Osteoarthritis
- (no location specified)
Sep 26, 2023
Novel MRI Biomarkers for Monitoring Disease Progression in ALS
Recruiting
- Amyotrophic Lateral Sclerosis
- Motor Neuron Disease
-
Miami, Florida
- +8 more
Jan 24, 2023
Non-Muscle Invasive Bladder Cancer, Self Efficacy, Smoking Behaviors Trial in Istanbul (Behavioral: Motivational Interviewing
Not yet recruiting
- Non-Muscle Invasive Bladder Cancer
- +4 more
- Behavioral: Motivational Interviewing with WhatsApp video call
-
Istanbul, Turkeyİrem Nur Ozdemir
Jan 20, 2023
Newly Oligodendroglioma Towards Secondary Glioma
Enrolling by invitation
- Oligodendroglioma, Adult
- Stressors
- (no location specified)
Sep 8, 2022
CKD Progression, Blood Pressure, Proteinuria Trial in Bangkok (Low salt diet)
Not yet recruiting
- CKD Progression
- +2 more
- Low salt diet
-
Bangkok, ThailandFaculty of Medicine,Vajira Hospital,Navamindradhiraj University
Feb 7, 2023
Parkinson Disease Trial in Lille (The FeetMe® Evaluation, the PKG® Watch,, MRI)
Recruiting
- Parkinson Disease
- The FeetMe® Evaluation
- +3 more
-
Lille, FranceHopital Roger Salengro, CHU Lille
Feb 28, 2022
Hereditary Transthyretin Amyloidosis
Recruiting
- Amyloidosis
- +6 more
-
Cleveland, OhioCleveland Clinic
Mar 11, 2022
Parkinson Disease Trial in New Haven (B-CIT and SPECT imaging)
Completed
- Parkinson Disease
- B-CIT and SPECT imaging
-
New Haven, ConnecticutInstitute for Neurodegenerative Disorders
Jul 1, 2022
Familial Hypereosinophilia: Natural History and Markers of
Recruiting
- Eosinophilia
- Hypereosinophilic Syndrome
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022
HIV Disease Progression Trial in Kampala (WhatsApp peer support group)
Recruiting
- HIV Disease Progression
- WhatsApp peer support group
-
Kampala, Bugolobi, Uganda
- +2 more
Jan 28, 2023
"Association of Proteinuria and Progression of Kidney
Completed
- Change in Albumin to Creatinine Ratio and Glomerular Filtration Rate
- Progression of Kidney Failure and or All-cause Mortality
- no intervention study
-
Creteil, FranceHenri Mondor Hospital
Jun 1, 2022
Patients With Limb Girdle Muscular Distrophy Type 2E
Completed
- LGMD2E
- Exon 3 truncating mutation
- Any other mutation in SGBC gene
-
Milano, ItalyIRCCS Ca' Granda Ospedale Maggiore Policlinico
Mar 29, 2022
NSCLC (NSCLC) Trial in Shanghai (Tumor treating fields(EFE-P100), Docetaxel injection)
Not yet recruiting
- Non-small Cell Lung Cancer (NSCLC)
- Tumor treating fields(EFE-P100)
- Docetaxel injection
-
Shanghai, ChinaShanghai Pulmonary Hospital
Dec 21, 2022
Metastatic Cancer, Solid Tumor Cancer, Lymphoproliferative Disorders Trial in Boulder (Written Exposure Therapy)
Recruiting
- Metastatic Cancer
- +5 more
- Written Exposure Therapy
-
Boulder, ColoradoUniversity of Colorado Boulder
Sep 13, 2023
Depression and Heart Failure Disease Progression
Completed
- Heart Failure
-
Durham, North CarolinaDuke University Medical Center
Dec 17, 2021
Progression Free Survival(PFS) Trial (Toposide capsules combined with anrotinib and Emvolizumab group)
Not yet recruiting
- Progression Free Survival(PFS)
- Toposide capsules combined with anrotinib and Emvolizumab group
- (no location specified)
Jan 13, 2023
Klotho as a Possible Biomarker of Peripheral Artery Disease
Recruiting
- Peripheral Arterial Disease
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Feb 24, 2023
Continuous and Wireless Vital Sign Monitoring in Patients at
Not yet recruiting
- Vital Sign Monitoring
- +3 more
- Wireless and continuously monitoring
-
Copenhagen, NV, DenmarkBispebjerg Hospital
Sep 7, 2022
Parkinson Disease Trial in Stockholm (Exenatide, Placebo)
Active, not recruiting
- Parkinson Disease
- Exenatide
- Placebo
-
Stockholm, SwedenAcademic Specialist Center, Center for Neurology, SLSO
Sep 12, 2022